Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Recruiting · NCT07096908 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tirzepatide Use in People With Obesity and Type 1 Diabetes | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 4 | 2026-04-20 | NCT07096908 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dasman Diabetes Institute | 8 |
| University of Ulster | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dasman Diabetes Institute | Kuwait City | Kuwait | 2 |